SCHEMBL6887769

SCHEMBL6887769

Cc1c(C(N)=O)cc(-c2ccccc2)c(C)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 2/20 0.56
BRD4 O60885 1/20 0.50
IKBKB O14920 8/20 0.46
PTGS1 P23219 1/20 0.45
CHUK O15111 4/20 0.44
IKBKE Q14164 1/20 0.44
PKMYT1 Q99640 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
DHODH Q02127 1/20 0.43
HDAC7 Q8WUI4 1/20 0.41
CASP1 P29466 1/20 0.41
CDC7 O00311 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CCNA1 P78396 1/20 0.41
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA3 P34903 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27721945 0.85 PTPN1 (0.49) PTGS1DHODHHDAC7
Ammonia Solution, Strong SCHEMBL27481370 0.84 PTPN1 (0.47) PTGS1DHODHHDAC7
SCHEMBL3898825 0.84 BCAT2 (0.58) BCAT2BRD4IKBKBCHUKIKBKE
SCHEMBL18816717 0.82 IKBKB (0.58) BCAT2BRD4IKBKBPTGS1CHUK
SCHEMBL27708585 0.80 BCAT2 (0.50) BCAT2BRD4IKBKBPTGS1CHUK
SCHEMBL7311563 0.80 BCAT2 (0.58) BCAT2BRD4IKBKBCHUKIKBKE
SCHEMBL9951887 0.79 BCAT2 (0.53) BCAT2BRD4IKBKBPTGS1CHUK
SCHEMBL26056188 0.78 DHODH (0.53) BCAT2BRD4IKBKBPTGS1DHODH
SCHEMBL29207452 0.77 PTGS1 (0.41) BCAT2PTGS1DHODHHDAC7GABRA1
SCHEMBL30034930 0.76 BCAT2 (0.69) BCAT2BRD4IKBKBSIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed